Rationale for the Radiation Therapy Oncology Group Study RTOG P-0014

類似資料

• Rationale for the Radiation Therapy Oncology Group Study RTOG P-0014
  著者:: Sandler, Howard M, 等
  出版事項: (2003)
• Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408
  著者:: Nichols, R. Charles, 等
  出版事項: (2017)
• A Dosimetric Analysis of Radiation Therapy Oncology Group (RTOG) 0321: the Importance of Urethral Dose
  著者:: Hsu, I-Chow, 等
  出版事項: (2013)
• A Phase III trial of 2 Years of Androgen Suppression (AS) and Radiation Therapy (RT) with or without Adjuvant Chemotherapy (CT) for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group (RTOG) Phase III Randomized Trial NRG Oncology RTOG 9902
  著者:: Rosenthal, Seth A., 等
  出版事項: (2015)
• Evaluation of nuclear factorκB and chemokine receptor CXCR4 co-expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610
  著者:: Okera, Meena, 等
  出版事項: (2010)